Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 31 | $1,356,323 |
Sells | 240 | $369,781,629 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 17,560 | 220 | 3,863,200 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 7,470 | 222 | 1,658,340 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | PYOTT DAVID E I | Director | 24 Jun 2024 | Sale | 7,420 | 221 | 1,639,820 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 78 | 221.71 | 17,293 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 17 | 224.17 | 3,811 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 24 | 225.55 | 5,413 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 45 | 226.82 | 10,207 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 169 | 228.3 | 38,583 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 348 | 229.06 | 79,713 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 398 | 229.93 | 91,512 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 129 | 231.59 | 29,875 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 283 | 232.54 | 65,809 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 151 | 233.53 | 35,263 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 242 | 234.66 | 56,788 | D |
26 Jun 2024 16:28 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GARG PUSHKAL | CMO & EVP Dev & Med Affairs | 25 Jun 2024 | Sale | 219 | 235.19 | 51,507 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 308 | 221.71 | 68,287 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 66 | 224.17 | 14,795 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 93 | 225.55 | 20,976 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 177 | 226.82 | 40,147 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 666 | 228.3 | 152,048 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,374 | 229.06 | 314,728 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,572 | 229.93 | 361,450 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 511 | 231.59 | 118,342 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 1,119 | 232.54 | 260,212 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 595 | 233.53 | 138,950 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 863 | 235.19 | 202,969 | D |
26 Jun 2024 16:27 | ALNY | ALNYLAM PHARMACEUTICALS Inc | GREENSTREET YVONNE | Chief Executive Officer | 25 Jun 2024 | Sale | 957 | 234.66 | 224,570 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | POULTON JEFFREY V. | EVP, Chief Financial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 59 | 221.71 | 13,081 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 13 | 224.17 | 2,914 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 18 | 225.55 | 4,060 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 34 | 226.82 | 7,712 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 129 | 228.3 | 29,451 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 266 | 229.06 | 60,930 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 304 | 229.93 | 69,899 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 99 | 231.59 | 22,927 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 216 | 232.54 | 50,229 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 115 | 233.53 | 26,856 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 185 | 234.66 | 43,412 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 25 Jun 2024 | Sale | 167 | 235.19 | 39,277 | D |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 24 Jun 2024 | Sale | 200 | 39 | 7,800 | D |
26 Jun 2024 16:26 | RVMD | Revolution Medicines Inc | KELSEY STEPHEN MICHAEL | See Remarks | 25 Jun 2024 | Sale | 16,467 | 39.057 | 643,152 | D |
26 Jun 2024 16:26 | IOT | Samsara Inc | BISWAS SANJIT | CHIEF EXECUTIVE OFFICER, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4917 | 2,831,203 | I |
26 Jun 2024 16:26 | PEPG | PepGen Inc | MELLION MICHELLE L | Chief Medical Officer | 24 Jun 2024 | Sale | 9,260 | 18.1887 | 168,427 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 45 | 221.71 | 9,977 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 9 | 224.17 | 2,018 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 13 | 225.55 | 2,932 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 26 | 226.82 | 5,897 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 96 | 228.3 | 21,917 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 198 | 229.06 | 45,354 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 227 | 229.93 | 52,194 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 74 | 231.59 | 17,138 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 161 | 232.54 | 37,439 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 86 | 233.53 | 20,084 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 138 | 234.66 | 32,383 | D |
26 Jun 2024 16:26 | ALNY | ALNYLAM PHARMACEUTICALS Inc | FITZGERALD KEVIN JOSEPH | CSO & EVP, Head of Research | 25 Jun 2024 | Sale | 125 | 235.19 | 29,399 | D |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 24 Jun 2024 | Purchase | 7,208 | 1.44 | 10,380 | I |
26 Jun 2024 16:25 | EXFY | Expensify Inc | MCLAUGHLIN STEVEN J. | 10% | 25 Jun 2024 | Purchase | 6,685 | 1.45 | 9,693 | I |
26 Jun 2024 16:25 | UPST | Upstart Holdings Inc | DATTA SANJAY | Chief Financial Officer | 24 Jun 2024 | Sale | 1,000 | 21.68 | 21,680 | D |
26 Jun 2024 16:24 | IOT | Samsara Inc | BICKET JOHN | SEE REMARKS, 10% | 25 Jun 2024 | Sale | 96,000 | 29.4912 | 2,831,155 | I |
26 Jun 2024 16:17 | HOV | HOVNANIAN ENTERPRISES INC | HOVNANIAN ARA K | Chairman of Bd., Pres. & CEO, 10% | 24 Jun 2024 | Sale | 2 | 148.305 | 297 | D |
26 Jun 2024 16:17 | HOV | HOVNANIAN ENTERPRISES INC | HOVNANIAN ARA K | Chairman of Bd., Pres. & CEO, 10% | 24 Jun 2024 | Sale | 1,296 | 145.11 | 188,063 | D |
26 Jun 2024 16:17 | HOV | HOVNANIAN ENTERPRISES INC | HOVNANIAN ARA K | Chairman of Bd., Pres. & CEO, 10% | 24 Jun 2024 | Sale | 644 | 146.107 | 94,093 | D |
26 Jun 2024 16:17 | HOV | HOVNANIAN ENTERPRISES INC | HOVNANIAN ARA K | Chairman of Bd., Pres. & CEO, 10% | 24 Jun 2024 | Sale | 2,606 | 147.565 | 384,554 | D |
26 Jun 2024 16:17 | UNF | UNIFIRST CORP | CROATTI MICHAEL A | Executive VP of Operations | 26 Jun 2024 | Sale | 1,800 | 169 | 304,200 | D |
26 Jun 2024 16:16 | GTII | Green Thumb Industries Inc | GEORGIADIS ANTHONY | PRESIDENT | 25 Jun 2024 | Sale | 35,115 | 12.15 | 426,647 | D |
26 Jun 2024 16:15 | GTII | Green Thumb Industries Inc | KOVLER BENJAMIN | CHAIRMAN & CEO, 10% | 25 Jun 2024 | Sale | 35,115 | 12.15 | 426,647 | D |
26 Jun 2024 16:15 | NYC | American Strategic Investment Co. | RADESCA NICHOLAS | Director | 24 Jun 2024 | Purchase | 2,500 | 9.0417 | 22,604 | D |
26 Jun 2024 16:15 | OBIO | Orchestra BioMed Holdings Inc | HOCHMAN DAVID P | See Remarks | 25 Jun 2024 | Purchase | 1,000 | 6.95 | 6,950 | I |
26 Jun 2024 16:15 | SPXC | SPX Technologies Inc | DATA J RANDALL | PRES., HEATING AND GLOBAL OPER | 24 Jun 2024 | Sale | 1,900 | 142.17 | 270,123 | D |
26 Jun 2024 16:15 | SPXC | SPX Technologies Inc | DATA J RANDALL | PRES., HEATING AND GLOBAL OPER | 24 Jun 2024 | Sale | 4,400 | 143.22 | 630,168 | D |
26 Jun 2024 16:15 | SPXC | SPX Technologies Inc | DATA J RANDALL | PRES., HEATING AND GLOBAL OPER | 24 Jun 2024 | Sale | 33,108 | 144.08 | 4,770,201 | D |
26 Jun 2024 16:15 | SPXC | SPX Technologies Inc | DATA J RANDALL | PRES., HEATING AND GLOBAL OPER | 24 Jun 2024 | Sale | 4 | 144.84 | 579 | D |
26 Jun 2024 16:15 | STTK | Shattuck Labs Inc | SCHREIBER TAYLOR | Chief Executive Officer | 26 Jun 2024 | Purchase | 14,400 | 3.473 | 50,011 | D |
26 Jun 2024 16:14 | HQI | HireQuest Inc | MALHOTRA R. RIMMY | Director | 24 Jun 2024 | Purchase | 2,000 | 12.2918 | 24,584 | D |
26 Jun 2024 16:11 | ULY | Urgent.ly Inc | BEN VOLKOW | Director | 24 Jun 2024 | Sale | 1,000 | 1.6505 | 1,650 | D |
26 Jun 2024 16:11 | ULY | Urgent.ly Inc | BEN VOLKOW | Director | 25 Jun 2024 | Sale | 800 | 1.5503 | 1,240 | D |
26 Jun 2024 16:10 | GRYP | Gryphon Digital Mining Inc | SALZMAN SIMEON | Chief Financial Officer | 21 Jun 2024 | Sale | 55,595 | 1.19 | 66,158 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 12,864 | 118.7148 | 1,527,147 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 24,506 | 119.6266 | 2,931,569 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 28,778 | 120.5003 | 3,467,758 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 6,670 | 121.6123 | 811,154 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 13,538 | 122.6929 | 1,661,016 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 13,044 | 123.5797 | 1,611,974 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 24 Jun 2024 | Sale | 600 | 124.3317 | 74,599 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 25 Jun 2024 | Sale | 3,001 | 119.8649 | 359,715 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 25 Jun 2024 | Sale | 10,964 | 120.9954 | 1,326,594 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 25 Jun 2024 | Sale | 2,850 | 122.9669 | 350,456 | D |
26 Jun 2024 16:09 | NVDA | NVIDIA CORP | KRESS COLETTE | EVP & Chief Financial Officer | 25 Jun 2024 | Sale | 25,560 | 121.8755 | 3,115,138 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)